Very long Detection Times after High and repeated intake of Heroin and Methadone, measured in Oral Fluid

[1] Drummer, O.H., (2006) Drug testing in oral fluid. Clin Biochem Rev 27: 147-159.Search in Google Scholar

[2] Caplan, Y.H., Goldberger, B.A. (2001) Alternative specimens for workplace drug testing. J Anal Toxicol 25: 396-399.10.1093/jat/25.5.39611499896Search in Google Scholar

[3] Vindenes, V., Yttredal, B., Oiestad, E.L., Waal, H., Bernard, J.P., Morland, J.G. et al. (2011) Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine. J Anal Toxicol 35: 32-39.10.1093/anatox/35.1.3221219701Search in Google Scholar

[4] Heltsley, R., Depriest, A., Black, D.L., Crouch, D.J., Robert, T., Marshall, L. et al. (2012) Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens. J Anal Toxicol 36: 75-80.10.1093/jat/bkr01922337775Search in Google Scholar

[5] Oiestad, E.L., Johansen, U., Christophersen, A.S. (2007) Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clin Chem 53: 300-309.10.1373/clinchem.2006.07423717158196Search in Google Scholar

[6] Langel, K., Gjerde, H., Favretto, D., Lillsunde, P., Oiestad, E.L., Ferrara, S.D. et al. (2013) Comparison of drug concentrations between whole blood and oral fluid. Drug Test. Anal.10.1002/dta.153224039237Search in Google Scholar

[7] Wille, S.M., Raes, E., Lillsunde, P., Gunnar, T., Laloup, M., Samyn, N. et al. (2009) Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit 31: 511-519.10.1097/FTD.0b013e3181ae46ea19571773Search in Google Scholar

[8] Kato, K., Hillsgrove, M., Weinhold, L., Gorelick, D.A., Darwin, W.D., Cone, E.J. (1993) Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions. J Anal Toxicol 17: 338-341.10.1093/jat/17.6.3388271779Search in Google Scholar

[9] Drummer, O.H., (2008) Introduction and review of collection techniques and applications of drug testing of oral fluid. Ther Drug Monit 30: 203-206.Search in Google Scholar

[10] Gray, T.R., Dams, R., Choo, R.E., Jones, H.E., Huestis, M.A. (2011) Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence. Forensic Sci Int 206: 98-102.10.1016/j.forsciint.2010.06.031301213420667673Search in Google Scholar

[11] Bosker, W.M., Huestis, M.A. (2009) Oral fluid testing for drugs of abuse. Clin Chem 55: 1910-1931.10.1373/clinchem.2008.108670316505419745062Search in Google Scholar

[12] Verstraete, A.G., (2004) Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 26: 200-205.10.1097/00007691-200404000-0002015228165Search in Google Scholar

[13] Presley, L., Lehrer, M., Seiter, W., Hahn, D., Rowland, B., Smith, M. et al. (2003) High prevalence of 6-acetylmorphine in morphine-positive oral fluid specimens. Forensic Sci Int 133: 22-25.10.1016/S0379-0738(03)00045-8Search in Google Scholar

[14] Cone, E.J., Welch, P., Paul, B.D., Mitchell, J.M. (1991) Forensic drug testing for opiates, III. Urinary excretion rates of morphine and codeine following codeine administration. J Anal. Toxicol. 15: 161-166.Search in Google Scholar

[15] Dams, R., Choo, R.E., Lambert, W.E., Jones, H., Huestis, M.A. (2007) Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug and Alcohol Dependence 87: 258-267.10.1016/j.drugalcdep.2006.08.020Search in Google Scholar

[16] Jenkins, A.J., Oyler, J.M., Cone, E.J. (1995) Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J Anal Toxicol 19: 359-374.10.1093/jat/19.6.359Search in Google Scholar

[17] Goldberger, B.A., Darwin, W.D., Grant, T.M., Allen, A.C., Caplan, Y.H., Cone, E.J. (1993) Measurement of heroin and its metabolites by isotope-dilution electronimpact mass spectrometry. Clin Chem 39: 670-675.10.1093/clinchem/39.4.670Search in Google Scholar

[18] Wang, W.L., Darwin, W.D., Cone, E.J. (1994) Simultaneous assay of cocaine, heroin and metabolites in hair, plasma, saliva and urine by gas chromatography-mass spectrometry. J Chromatogr. B Biomed. Appl 660: 279-290.Search in Google Scholar

[19] Kim, I., Barnes, A.J., Oyler, J.M., Schepers, R., Joseph, R.E., Jr., Cone, E.J. et al. (2002) Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration. Clin Chem 48: 1486-1496.10.1093/clinchem/48.9.1486Search in Google Scholar

[20] Bernard, J.P., Morland, J., Krogh, M., Khiabani, H.Z. (2009) Methadone and impairment in apprehended drivers. Addiction 104: 457-464.10.1111/j.1360-0443.2008.02470.xSearch in Google Scholar

[21] Chikhi-Chorfi, N., Pham-Huy, C., Galons, H., Manuel, N., Lowenstein, W., Warnet, J.M. et al. (1998) Rapid determination of methadone and its major metabolite in biological fluids by gas-liquid chromatography with thermionic detection for maintenance treatment of opiate addicts. J Chromatogr. B Biomed. Sci Appl 718: 278-284.10.1016/S0378-4347(98)00375-2Search in Google Scholar

[22] Shiran, M.R., Hassanzadeh-Khayyat, M., Iqbal, M.Z., Lagundoye, O., Seivewright, N., Lennard, M.S. et al. (2005) Can saliva replace plasma for the monitoring of methadone? Ther Drug Monit 27: 580-586.10.1097/01.ftd.0000164392.01779.db16175130Search in Google Scholar

[23] Vindenes, V., Jordbru, D., Knapskog, A.B., Kvan, E., Mathisrud, G., Slordal, L. et al. (2012) Impairment based legislative limits for driving under the influence of nonalcohol drugs in Norway. Forensic Sci Int 219: 1-11.10.1016/j.forsciint.2011.11.00422118917Search in Google Scholar

[24] Laloup, M., Del Mar Ramirez, F.M., Wood, M., De, B.G., Maes, V., Samyn, N. (2006) Correlation of Delta9-tetrahydrocannabinol concentrations determined by LCMS- MS in oral fluid and plasma from impaired drivers and evaluation of the onsite Drager DrugTest. Forensic Sci Int 161: 175-179.10.1016/j.forsciint.2006.03.03316842950Search in Google Scholar

[25] Cone, E.J., Clarke, J., Tsanaclis, L. (2007) Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid. J Anal Toxicol 31: 424-433.10.1093/jat/31.8.42417988455Search in Google Scholar

[26] Gjerde, H., Christophersen, A.S., Normann, P.T., Assum, T., Oiestad, E.L., Morland, J. (2013) Norwegian roadside survey of alcohol and drug use by drivers (2008-2009). Traffic. Inj. Prev. 14: 443-452.Search in Google Scholar

[27] Lund, H.M., Oiestad, E.L., Gjerde, H., Christophersen, A.S. (2011) Drugs of abuse in oral fluid collected by two different sample kits--stability testing and validation using ultra performance tandem mass spectrometry analysis. J Chromatogr. B Analyt. Technol Biomed. Life Sci 879: 3367-3377.Search in Google Scholar

[28] Berg, T., Lundanes, E., Christophersen, A.S., Strand, D.H. (2009) Determination of opiates and cocaine in urine by high pH mobile phase reversed phase UPLC-MS/ MS. J Chromatogr. B Analyt. Technol Biomed. Life Sci 877: 421-432.Search in Google Scholar

[29] Hegstad, S., Khiabani, H.Z., Oiestad, E.L., Berg, T., Christophersen, A.S. (2007) Rapid quantification of buprenorphine-glucuronide and norbuprenorphineglucuronide in human urine by LC-MS-MS. J Anal Toxicol 31: 214-219.10.1093/jat/31.4.21417555645Search in Google Scholar

[30] Oiestad, E.L., Johansen, U., Oiestad, A.M., Christophersen, A.S. (2011) Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry. J Anal Toxicol 35: 280-293.10.1093/anatox/35.5.28021619723Search in Google Scholar

[31] Karinen, R., Andersen, J.M., Ripel, A., Hasvold, I., Hopen, A.B., Morland, J. et al. (2009) Determination of heroin and its main metabolites in small sample volumes of whole blood and brain tissue by reversed-phase liquid chromatographytandem mass spectrometry. J Anal Toxicol 33: 345-350.10.1093/jat/33.7.34519796503Search in Google Scholar

[32] Øiestad EL, Johansen U, and et al. Determination of synthetic cannabinoids in oral fluid with ultra performance tandem mass spectrometry UPLC-MS/MS. TIAFT Hamamatsu 2012. P-187. 2012. Ref Type: Conference ProceedingSearch in Google Scholar

[33] Cone, E.J., Huestis, M.A. (2007) Interpretation of oral fluid tests for drugs of abuse. Ann N Y Acad. Sci 1098: 51-103.Search in Google Scholar

[34] Phillips, S.G., Allen, K.R. (2006) Acetylcodeine as a marker of illicit heroin abuse in oral fluid samples. J Anal Toxicol 30: 370-374.10.1093/jat/30.6.37016872567Search in Google Scholar

[35] Toennes, S.W., Steinmeyer, S., Maurer, H.J., Moeller, M.R., Kauert, G.F. (2005) Screening for drugs of abuse in oral fluid--correlation of analysis results with serum in forensic cases. J Anal Toxicol 29: 22-27.10.1093/jat/29.1.2215808009Search in Google Scholar

[36] Lee, D., Milman, G., Barnes, A.J., Goodwin, R.S., Hirvonen, J., Huestis, M.A. (2011) Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence. Clin Chem 57: 1127-1136.10.1373/clinchem.2011.16482221677094Search in Google Scholar

[37] Smith-Kielland, A., Skuterud, B., Morland, J. (1999) Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J Anal. Toxicol. 23: 323-332. Search in Google Scholar